Metrion Biosciences

Metrion Biosciences Limited is a UK-based contract research organization specializing in high-quality ion channel screening and drug development. Our goal is to provide customers with a range of in vitro screening services, including cardiac safety (hERG, CiPA panel of human cardiac ion channels) and neuropathology assays. We take pride in offering a flexible and cost-effective service with a professional approach. Overall, our management team has accumulated extensive experience in ion channel drug development, and our customers can benefit from this high level of expertise as part of our specialized services. We provide high-quality ion channel drugs and services to customers on a fee-for-service or collaborative basis. The company is also a leading provider of cardiac safety analysis, cardiac translational assays, and neuro-translational assays.